In the late 1960s, a group of scientists and volunteers at UCLA came together to develop a cancer center they hoped would become renowned for excellence in research, education and patient care. Today, UCLA Health’s Jonsson [...]
Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma.
What is CAR T-cell therapy?
Medical researchers have had breakthroughs in treating certain types of cancer by bolstering a patient’s immune system. Known as immunotherapy, or biologic therapy, it treats cancer differently than established treatments such as chemotherapy, radiation, bone marrow transplant and surgery.
To date, the U.S. Food and [...]
18-Year Brain Tumor Survivor Thriving from 3rd Awake Brain Surgery & Immunotherapy Vaccine from Dr. Linda Liau at UCLA
Jeannine Walston shares her story, with detailed information about her experience at UCLA, Dr. Liau, brain surgery, immunotherapy vaccine, and how to support research.